Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.

Antimicrob Agents Chemother

Astellas Pharma US, Inc., 3 Parkway North, Deerfield, IL 60015-2548, USA.

Published: February 2007

We assessed the pharmacokinetics and interactions of steady-state micafungin (Mycamine) or placebo with steady-state voriconazole in 35 volunteers. The 90% confidence intervals around the least-squares mean ratios for micafungin pharmacokinetic parameters and placebo-corrected voriconazole pharmacokinetic parameters were within the 80%-to-125% limits, indicating an absence of drug interaction.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797737PMC
http://dx.doi.org/10.1128/AAC.00673-06DOI Listing

Publication Analysis

Top Keywords

pharmacokinetic parameters
8
steady-state pharmacokinetics
4
pharmacokinetics micafungin
4
micafungin voriconazole
4
voriconazole separate
4
separate concomitant
4
concomitant dosing
4
dosing healthy
4
healthy adults
4
adults assessed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!